The Procter & Gamble Company (NYSE:PG) Shares Purchased by Fidelis Capital Partners LLC

Fidelis Capital Partners LLC grew its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 22.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,776 shares of the company’s stock after acquiring an additional 2,933 shares during the quarter. Fidelis Capital Partners LLC’s holdings in Procter & Gamble were worth $2,312,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Wyrmwood Management LLC purchased a new stake in shares of Procter & Gamble during the 4th quarter worth about $29,000. Mendota Financial Group LLC boosted its stake in shares of Procter & Gamble by 636.6% during the 4th quarter. Mendota Financial Group LLC now owns 302 shares of the company’s stock valued at $44,000 after buying an additional 261 shares during the last quarter. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at approximately $50,000. Morton Brown Family Wealth LLC boosted its stake in shares of Procter & Gamble by 206.6% during the 4th quarter. Morton Brown Family Wealth LLC now owns 417 shares of the company’s stock valued at $61,000 after buying an additional 281 shares during the last quarter. Finally, Activest Wealth Management boosted its stake in shares of Procter & Gamble by 49.7% during the 4th quarter. Activest Wealth Management now owns 455 shares of the company’s stock valued at $67,000 after buying an additional 151 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on PG. Stifel Nicolaus upped their price target on Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a research report on Wednesday, January 24th. Royal Bank of Canada upped their price target on Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 24th. Barclays upped their price target on Procter & Gamble from $165.00 to $168.00 and gave the company an “overweight” rating in a research report on Friday, April 12th. Raymond James upped their price target on Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a research report on Wednesday, January 24th. Finally, Wells Fargo & Company upped their price target on Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a research report on Wednesday, January 24th. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $168.53.

Get Our Latest Analysis on Procter & Gamble

Procter & Gamble Price Performance

PG stock traded up $0.20 during trading hours on Thursday, hitting $157.16. 7,812,560 shares of the stock traded hands, compared to its average volume of 6,858,717. The stock has a 50-day simple moving average of $159.16 and a 200 day simple moving average of $152.80. The Procter & Gamble Company has a one year low of $141.45 and a one year high of $163.14. The company has a market cap of $369.80 billion, a P/E ratio of 26.22, a P/E/G ratio of 3.19 and a beta of 0.44. The company has a current ratio of 0.64, a quick ratio of 0.44 and a debt-to-equity ratio of 0.48.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Tuesday, January 23rd. The company reported $1.84 earnings per share for the quarter, beating the consensus estimate of $1.70 by $0.14. Procter & Gamble had a return on equity of 34.04% and a net margin of 17.60%. The business had revenue of $21.44 billion during the quarter, compared to analysts’ expectations of $21.48 billion. During the same quarter last year, the business posted $1.59 earnings per share. The company’s quarterly revenue was up 3.2% on a year-over-year basis. Equities analysts forecast that The Procter & Gamble Company will post 6.45 earnings per share for the current year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a $1.0065 dividend. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.56%. Procter & Gamble’s dividend payout ratio (DPR) is 62.98%.

Insiders Place Their Bets

In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the firm’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the sale, the chief executive officer now directly owns 4,859 shares in the company, valued at approximately $768,256.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CEO Gary A. Coombe sold 22,000 shares of Procter & Gamble stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the completion of the sale, the chief executive officer now directly owns 36,845 shares in the company, valued at approximately $5,943,835.40. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO R. Alexandra Keith sold 776 shares of Procter & Gamble stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total value of $122,693.36. Following the sale, the chief executive officer now owns 4,859 shares of the company’s stock, valued at $768,256.49. The disclosure for this sale can be found here. In the last ninety days, insiders sold 279,063 shares of company stock worth $43,187,745. 0.17% of the stock is currently owned by company insiders.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.